Merck

PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Journal of cell science (2001-11-01)
M A Lawlor, D R Alessi
RESUMO

The serine/threonine protein kinase PKB (also known as Akt) is thought to be a key mediator of signal transduction processes. The identification of PKB substrates and the role PKB phosphorylation plays in regulating these molecules have been a major focus of research in recent years. A recently developed motif-profile scoring algorithm that can be used to scan the genome for potential PKB substrates is therefore a useful tool, although additional considerations, such as the evolutionary conservation of the phosphorylation site, must also be taken into account. Recent evidence indicates that PKB plays a key role in cancer progression by stimulating cell proliferation and inhibiting apoptosis and is also probably a key mediator of insulin signalling. These findings indicate that PKB is likely to be a hot drug target for the treatment of cancer, diabetes and stroke. There are, however, a number of pitfalls of methodologies currently employed to study PKB function, and therefore caution should be used in interpretation of such experiments.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anti-phospho-PKB (pSer473) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-phospho-PKB (pThr308) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution